Oncology Pharma Stock Forecast
Oncology Pharma Stock Forecast. View onph's stock price, price target, earnings, forecast, insider trades, and news at marketbeat. Elev), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with.
Oncology pharma inc otc updated feb 23, 2022 8:55 pm. Oncology pharma inc (onph) stock forecast and price target. During the day the stock fluctuated 34.09% from a day low at $4.40 to a day high of $5.90.
Oncology Pharma Stock Price Has Been Showing A Declining Tendency So We Believe That Similar Market Segments Were Not Very Popular In The Given Period.
About the oncology pharma, inc. Elev), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with. Onph 5.36 0.40 (8.02%) 1,575.
Over The Next 52 Weeks, Oncology Pharma Inc Has On Average Historically Risen By 145.7 % Based On The Past 25 Years Of Stock Performance.
230 rows oncology pharma inc stock price forecast, onph predictons for2022 View onph's stock price, price target, earnings, forecast, insider trades, and news at marketbeat. Oncology pharma inc (onph) company description.
Oncology Pharma Stock Forecast, Onph Stock Price Prediction.
Onph | complete oncology pharma inc. During the day the stock fluctuated 34.09% from a day low at $4.40 to a day high of $5.90. Close price at the end of the last trading day (friday, 25th feb 2022) of the onph stock was $5.10.
Onph Oncology Pharma Inc — Stock Price And Discussion | Stocktwits.
And has now fallen 4 days in a row. During the day the stock fluctuated 3.39% from a day low at $5.02 to a day high of $5.19. Is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics.
Participation From Market Makers And Ecns Is Strictly Voluntary And As A Result, These.
Price target in 14 days: However, solely looking at the historical price movement is usually misleading. This is 0.99% more than the trading day before thursday, 24th feb 2022.
Post a Comment for "Oncology Pharma Stock Forecast"